Scinovex
review Open AccessTop 1% cited

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

Diabetologia · 2012 · Vol. 55(4) · pp. 885–904
Giovanni MussoMaurizio CassaderF. RosinaRoberto Gambino
Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseAlcohol Consumption and Health EffectsFatty liverMedicineSteatohepatitisPioglitazoneInternal medicineSteatosisInsulin resistanceDiabetes mellitusGastroenterologyMetformin

MeSH terms

Cardiovascular DiseasesFatty LiverGlucoseHumansLiver DiseasesRiskRandomized Controlled Trials as Topic

Funding

  • Regione Piemonte
Citations
664
FWCI
33.07
field-weighted impact
References
141
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.